ARCHIVES

FDA Approves Ribavirin Phase 102 Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 42 | October 30, 1987

Download PDF Visit The Full Archive

Related Articles

Capitol Hill: Senators Reintroduce Breast Cancer Stamp.

January 28, 2005

NIH Review Division Considering Proposal For Clinical Oncology Study Section

October 10, 1997

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

FASEB Delivers Its Recommendations For Federal Research Funding in 2013

February 3, 2012

ASCO Urges Increase In NIH, NCI Budgets.

January 25, 2008

Study: Negative HPV Test More Accurate than Negative Pap Test In Predicting Cervical Cancer Risk

July 25, 2014